

| Catalog No. | HB201013 |
|---|---|
| Description |
Anti-Human HTR2A Nanobody (SAA1362) [SAA1362] (HB201013) is a alpaca monoclonal antibody detecting HTR2A in IP. Suitable for Human.
|
| Species reactivity | Human |
| Applications | IP |
| Host species | Alpaca |
| Clonality | Monoclonal |
| Isotype | VHH-8His-Cys-tag |
| Clone ID | SAA1362 |
| Target | 5-HT-2A, 5-hydroxytryptamine receptor 2A, Serotonin receptor 2A, HTR2A, 5-HT-2, HTR2 |
| Endotoxin level | < 10 EU/mg as determined by LAL method. |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Purified by Nickel column. |
| Accession | P28223 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Background | 5-hydroxytryptamine receptor 2A (HTR2A) is a ~52 kDa protein. G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including mescaline, psilocybin, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors. HTR2A is coupled to G(q)/G(11) G alpha proteins and activates phospholipase C-beta, releasing diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) second messengers that modulate the activity of phosphatidylinositol 3-kinase and promote the release of Ca(2+) ions from intracellular stores, respectively. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. 1. Stam, NJ. et al. (1992) European journal of pharmacology 227, 153-62. PMID: 1330647 2. Cussac, D. et al. (2008) European journal of pharmacology 594, 32-8. PMID: 18703043 3. Knauer, CS. et al. (2009) Naunyn-Schmiedeberg's archives of pharmacology 379, 461-71. PMID: 19057895 4. Albizu, L. et al. (2011) Neuropharmacology 61, 770-7. PMID: 21645528 5. Delille, HK. et al. (2012) Neuropharmacology 62, 2184-91. PMID: 22300836 6. Cao, D. et al. (2022) Science (New York, N.Y.) 375, 403-411. PMID: 35084960 7. Chen, Z. et al. (2024) Cell 187, 2194-2208.e22. PMID: 38552625 8. Wacker, D. et al. (2017) Cell 168, 377-389.e12. PMID: 28129538 9. González-Maeso, J. et al. (2008) Nature 452, 93-7. PMID: 18297054 |
| Note | For research use only. |

SDS-PAGE for Anti-Human HTR2A Recombinant Nanobody (SAA1362)
Contact us for custom quotes, bulk requests and any other issues.
Mail: [email protected]


Quick access
Contact Us
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский